secwatch.observer — SEC 8-K summary
======================================

Issuer:     Scilex Holding Co (SCLX)
CIK:        0001820190
Form:       8-K
Filed at:   2026-07-06T10:15:40+00:00
Accession:  0001193125-26-295493
Event type: other_material
Sentiment:  positive
Materiality: 0.75
Item codes: 1.01, 3.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Scilex signs binding term sheet for $100M investment from iHolding at $15/share
-------------------------------------------------------------------------------

- iHolding to purchase $100M of newly issued shares at $15/share (~6.67M shares).
- Investment subject to due diligence, definitive agreements, board/stockholder approvals, regulatory approvals.
- Proceeds to support strategic growth, including product development, acquisitions, working capital.
- iHolding is a Kazakhstan-based private investment group; one of largest Kazakhstan-origin healthcare investments into US-listed biopharma.
- No assurance of consummation; risks of termination or litigation.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1820190/000119312526295493/0001193125-26-295493-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1820190/000119312526295493/sclx-20260703.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-295493

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer